Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Treasury Shares: 2021-2025

Historic Treasury Shares for Core Scientific (CORZ) over the last 4 years, with Sep 2025 value amounting to $15.7 million.

  • Core Scientific's Treasury Shares fell 22.37% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 22.37%. This contributed to the annual value of $18.3 million for FY2024, which is 52.18% down from last year.
  • Core Scientific's Treasury Shares amounted to $15.7 million in Q3 2025, which was down 8.80% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Treasury Shares ranged from a high of $96.9 million in Q1 2022 and a low of $1.1 million during Q1 2024.
  • Its 3-year average for Treasury Shares is $24.2 million, with a median of $19.8 million in 2024.
  • As far as peak fluctuations go, Core Scientific's Treasury Shares crashed by 97.28% in 2024, and later soared by 1,354.55% in 2025.
  • Over the past 5 years, Core Scientific's Treasury Shares (Quarterly) stood at $88.6 million in 2021, then tumbled by 48.97% to $45.2 million in 2022, then dropped by 15.17% to $38.4 million in 2023, then plummeted by 52.18% to $18.3 million in 2024, then fell by 22.37% to $15.7 million in 2025.
  • Its Treasury Shares stands at $15.7 million for Q3 2025, versus $17.2 million for Q2 2025 and $16.0 million for Q1 2025.